City

Beijing (1)

Condition

Effect of Drug (1)

Secondary Resistance (1)

Toxicity, Drug (1)

Overall Status

Completed (1)

Sign in for free

Phase

n/a (1)

Sponsor

Peking University People's Hospital (1)

Collaborator

Peking University Shougang Hospital (1)

Intervention

apatinib mesylate (1)

ifosfamide and etoposide (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

secondary resistance

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed

Effect of Drug
+2 more

Apatinib Mesylate
ifosfamide and etoposide

Beijing, Beijing, China

Peking University People's Hospital

Mar 12, 2022